Principles of local drug delivery to the inner ear

Audiology and Neurotology

Volumn 14, Issue 6, 2009, Pages 350-360

  Salt, Alec N ^a   Plontke, Stefan K ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Animal; Cochlea; Controlled release; Human; Inner ear; Local drug delivery; Perilymph; Pharmacokinetics

Indexed keywords

EID: 73349112869     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000241892     Document Type: Review

References (84)

1. Ersner MS, Spiegel EA, Alexander MH: Transtympanic injection of anesthetics for the treatment of Ménière's syndrome. AMA Arch Otolaryngol 1951; 54: 43-52.
2. Völger G: Beseitigung von Labyrinthliquordruckstörungen bei dem Menièrschen Symptomkomplex durch das Hyaluronidasepräparat Kinetin (in German). HNO 1952; 3: 142-147.
3. Schuknecht HF: Ablation therapy for the relief of Ménière's disease. Laryngoscope 1956; 66: 859-870.
4. Lange G: Gentamicin and other ototoxic antibiotics for the transtympanic treatment of Menière's disease. Arch Otorhinolaryngol 1989; 246: 269-270.
5. Blakley BW: Clinical forum: A review of intratympanic therapy. Am J Otol 1997; 18: 520-526.
6. Carey J: Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo. Otolaryngol Clin North Am 2004; 37: 1075-1090.
7. Schwab B, Lenarz T, Heermann R: Use of the round window micro cath for inner ear therapy - results of a placebo-controlled, prospective study on chronic tinnitus (in German). Laryngorhinootologie 2004; 83: 164-172.
8. Van Wijk F, Staecker H, Keithley E, Lefebvre PP: Local perfusion of the tumor necrosis factor alpha blocker infliximab to the inner ear improves autoimmune neurosensory hearing loss. Audiol Neurootol 2006; 11: 357-365.
9. Suckfuell M, Canis M, Strieth S, Scherer H, Haisch A: Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: A prospective randomized phase I/II study. Acta Otolaryngol 2007; 127: 938-942.
10. Barrs DM: Intratympanic corticosteroids for Meniere's disease and vertigo. Otolaryngol Clin North Am 2004; 37: 955-972.
11. Rauch SD: Intratympanic steroids for sensorineural hearing loss. Otolaryngol Clin North Am 2004; 37: 1061-1074.
12. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF: Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117: 3-15.
13. Plontke SK, Löwenheim H, Mertens J, Engel C, Meisner C, Weidner A, Zimmermann R, Preyer S, Koitschev A, Zenner HP: Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009; 119: 359-369.
14. Light JP, Silverstein H: Transtympanic perfusion: Indications and limitations. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 378-383.
15. Sakata E, Ito Y, Itoh A: Clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J 1997; 3: 117-121.
16. Harris JP: Inner ear steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2007; 15: 303.
17. Hamid M, Trune D: Issues, indications, and controversies regarding intratympanic steroid perfusion. Curr Opin Otolaryngol Head Neck Surg 2008; 16: 434-440.
18. Arnold W, Senn P, Hennig M, Michaelis C, Deingruber K, Scheler R, Steinhoff HJ, Riphagen F, Lamm K: Novel slow-and fasttype drug release round-window microimplants for local drug application to the cochlea: An experimental study in guinea pigs. Audiol Neurootol 2005; 10: 53-63.
19. Endo T, Nakagawa T, Kita T, Iguchi F, Kim TS, Tamura T, Iwai K, Tabata Y, Ito J: Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 2005; 115: 2016-2020.
20. Tamura T, Kita T, Nakagawa T, Endo T, Kim TS, Ishihara T, Mizushima Y, Higaki M, Ito J: Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 2005; 115: 2000-2005.
21. Ge X, Jackson RL, Liu J, Harper EA, Hoffer ME, Wassel RA, Dormer KJ, Kopke RD, Balough BJ: Distribution of PLGA nanoparticles in chinchilla cochleae. Otolaryngol Head Neck Surg 2007; 137: 619-623.
22. Paulson DP, Abuzeid W, Jiang H, Oe T, O'Malley BW, Li D: A novel controlled local drug delivery system for inner ear disease. Laryngoscope 2008; 118: 706-711.
23. Goycoolea MV, Lundman L: Round window membrane. Structure function and permeability: A review. Microsc Res Tech 1997; 36: 201-211.
24. Goycoolea MV: Clinical aspects of round window membrane permeability under normal and pathological conditions. Acta Otolaryngol 2001; 121: 437-447.
25. Schachern PA, Paparella MM, Duvall AJ 3rd: The normal chinchilla round window membrane. Arch Otolaryngol 1982; 108: 550-554.
26. Rahm WE, Strother WF, Gulick WL, Crump JF: The effects of topical anesthetics upon the ear. Ann Otol Rhinol Laryngol 1959; 68: 1037-1046.
27. Imamura S, Adams JC: Distribution of gentamicin in the guinea pig inner ear after local or systemic application. J Assoc Res Otolaryngol 2003; 2: 176-195.
28. Wagner N, Cayé-Thomasen P, Laurell G, Bagger-Sjöbäck D, Thomsen J: Cochlear hair cell loss in single-dose versus continuous round window administration of gentamicin. Acta Otolaryngol 2005; 125: 340-345.
29. Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: An animal study followed by clinical application. Laryngoscope 1999; 109: 1-17.
30. Liu HJ, Dong MM, Chi FL: Dexamethasone pharmacokinetics in guinea pig inner ear perilymph. ORL J Otorhinolaryngol Relat Spec 2006; 68: 93-98.
31. Yang J, Wu H, Zhang P, Hou DM, Chen J, Zhang SG: The pharmacokinetic profiles of dexamethasone and methylprednisolone concentration in perilymph and plasma following systemic and local administration. Acta Otolaryngol 2008; 128: 496-504.
32. Thorne M, Salt AN, DeMott JE, Henson MM, Henson OW, Gewalt SL: Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999; 109: 1661-1668.
33. Salt AN, Kellner C, Hale S: Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid. Hear Res 2003; 182: 24-33.
34. Mynatt R, Hale SA, Gill RM, Plontke SKR, Salt AN: Demonstration of a longitudinal concentration gradient along scala tympani by sequential sampling of perilymph from the cochlear apex. J Assoc Res Otolaryngol 2006; 7: 182-193.
35. Stöver T, Yagi M, Raphael Y: Cochlear gene transfer: Round window versus cochleostomy inoculation. Hear Res 1999; 136: 124-130.
36. Saijo S, Kimura RS: Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 1984; 97: 593-610.
37. Hahn H, Kammerer B, DiMauro A, Salt AN, Plontke S: Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear Res 2006; 212: 236-244.
38. Höft J: The permeability of the round window membrane and its changes by pantocaine (tetracaine). Arch Klin Exp Ohren Nasen Kehlkopfheilkd 1969; 193: 128-137.
39. Ikeda K, Morizono T: Changes of the permeability of round window membrane in otitis media. Arch Otolaryngol Head Neck Surg 1988; 114: 895-897.
40. Selivanova O, Maurer J, Ecke U, Mann WJ: The effects of Streptolysin-O and sodium hyaluronate on the permeability of the round window membrane in guinea pigs - an electrophysiologic study (in German). Laryngorhinootologie 2003; 82: 235-239.
41. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, Baredes S: Dexamethasone pharmacokinetics in the inner ear: Comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000; 122: 521-528.
42. Mikulec AA, Hartsock JJ, Salt AN: Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol 2008; 29: 1020-1026.
43. Tanaka K, Motomura S: Permeability of the labyrinthine windows in guinea pigs. Arch Otorhinolaryngol 1981; 233: 67-73.
44. Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea. I. Estimation by tracer perfusion. Hear Res 1991; 56: 29-36.
45. Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea. II. Estimation by bolus injection of tracer into the sealed cochlea. Hear Res 1991; 56: 37-43.
46. Mikulec AA, Plontke SK, Hartsock JJ, Salt AN: Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: Implications for local drug delivery in humans. Otol Neurotol 2009; 30: 131-138.
47. Shepherd RK, Colreavy MP: Surface microstructure of the perilymphatic space: Implications for cochlear implants and cell-or drug-based therapies. Arch Otolaryngol Head Neck Surg 2004; 130: 518-523.
48. Rask-Andersen H, Schrott-Fischer A, Pfaller K, Glueckert R: Perilymph/modiolar communication routes in the human cochlea. Ear Hear 2006; 27: 457-465.
49. Ilberg C, Vosteen KH: Permeability of the inner ear membranes. Acta Otolaryngol 1969; 67: 165-170.
50. Richardson RT, O'Leary S, Wise A, Hardman J, Clark G: A single dose of neurotrophin-3 to the cochlea surrounds spiral ganglion neurons and provides trophic support. Hear Res 2005; 204: 37-47.
51. Salt AN, DeMott JE: Endolymph volume changes during osmotic dehydration measured by two marker techniques. Hear Res 1995; 90: 12-23.
52. Swan EE, Mescher MJ, Sewell WF, Tao SL, Borenstein JT: Inner ear drug delivery for auditory applications. Adv Drug Deliv Rev 2008; 60: 1583-1599.
53. Plontke SK, Mynatt R, Gill RM, Salt AN: Concentration gradient along scala tympani following the local application of gentamicin to the round window membrane. Laryngoscope 2007; 117: 1191-1198.
54. Plontke SK, Biegner T, Kammerer B, Delabar U, Salt AN: Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otology Neurotol 2008; 29: 401-406.
55. Hargunani CA, Kempton JB, DeGagne JM, Trune DR: Intratympanic injection of dexamethasone: Time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006; 27: 564-569.
56. Housley GD: Extracellular nucleotide signaling in the inner ear. Mol Neurobiol 1998; 16: 21-48.
57. Vlajkovic SM, Housley GD, Muñoz DJ, Robson SC, Sévigny J, Wang CJ, Thorne PR: Noise exposure induces up-regulation of ecto-nucleoside triphosphate diphosphohydrolases 1 and 2 in rat cochlea. Neuroscience 2004; 126: 763-773.
58. Hibi T, Suzuki T, Nakashima T: Perilymphatic concentration of gentamicin administered intratympanically in guinea pigs. Acta Otolaryngol 2001; 121: 336-341.
59. Hoffer ME, Balough B, Kopke RD, et al: Morphologic changes in the inner ear of Chinchilla laniger after middle ear administration of gentamicin in a sustained-release vehicle. Otolaryngol Head Neck Surg 1999; 120: 643-648.
60. Plontke SK, Wood AW, Salt AN: Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002; 23: 967-974.
61. Bachmann G, Su J, Zumegen C, Wittekindt C, Michel O: Permeabilität der runden Fenstermembran für Prednisolon-21-Hydrogensuccinat. HNO 2001; 49: 538-542.
62. Plontke SK, Salt AN: Quantitative interpretation of corticosteroid pharmacokinetics in inner ear fluids using computer simulations. Hear Res 2003; 182: 34-42.
63. Hughes PM, Olejnik O, Chang-Lin JE, Wilson CG: Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev 2005; 57: 2010-2032.
64. Salt AN, Gill RM, Plontke SK: Dependence of hearing changes on the dose of intratympanically-applied gentamicin: A metaanalysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope 2008; 118: 1793-1800.
65. Shea JJ Jr: The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997; 30: 1051-1059.
66. Salt AN, Hale SA, Plonkte SK: Perilymph sampling from the cochlear apex: A reliable method to obtain higher purity perilymph samples from scala tympani. J Neurosci Methods 2006; 153: 121-129.
67. Salt AN, Sirjani DB, Hartsock JJ, Gill RM, Plontke SK: Marker retention in the cochlea following injections through the round window membrane. Hear Res 2007; 232: 78-86.
68. Chen Z, Kujawa SG, McKenna MJ, Fiering JO, Mescher MJ, Borenstein JT, Swan EE, Sewell WF: Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J Control Release 2005; 110: 1-19.
69. Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J: Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear 2007; 28: 361-369.
70. James DP, Eastwood H, Richardson RT, O'Leary SJ: Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurootol 2008; 13: 86-96.
71. Vivero RJ, Joseph DE, Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van de Water TR: Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 2008; 118: 2028-2035.
72. Lehnhardt E: Intracochlear placement of cochlear implant electrodes in soft surgery technique HNO (in German). 1993; 41: 356-359.
73. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004; 124: 272-280.
74. Gantz BJ, Turner C, Gfeller KE, Lowder MW: Preservation of hearing in cochlear implant surgery: Advantages of combined electrical and acoustical speech processing. Laryngoscope 2005; 115: 796-802.
75. Richardson RT, Thompson B, Moulton S, Newbold C, Lum MG, Cameron A, Wallace G, Kapsa R, Clark G, O'Leary S: The effect of polypyrrole with incorporated neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials 2007; 28: 513-523.
76. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR: Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 2007; 226: 168-177.
77. Bird PA, Begg EJ, Zhang M, Keast AT, Murray DP, Balkany TJ: Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otol Neurotol 2007; 28: 1124-1130.
78. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004; 124: 272-280.
79. Paasche G, Tasche C, Stöver T, Lesinski-Schiedat A, Lenarz T: The long-term effects of modified electrode surfaces and intracochlear corticosteroids on postoperative impedances in cochlear implant patients. Otol Neurotol 2009; 30: 592-598.
80. Garnham C, Reetz G, Jolly C, Miller J, Salt A, Beal F: Drug delivery to the cochlea after implantation: Consideration of the risk factors. Cochlear Implants Int 2005; 6(suppl 1):12-14.
81. Hochmair I, Nopp P, Jolly C, Schmidt M, Schösser H, Garnham C, Anderson I: MEDEL cochlear implants: State of the art and a glimpse into the future. Trends Amplif 2006; 10: 201-219.
82. Richardson RT, Wise AK, Thompson BC, Flynn BO, Atkinson PJ, Fretwell NJ, Fallon JB, Wallace GG, Shepherd RK, Clark GM, O'Leary SJ: Polypyrrole-coated electrodes for the delivery of charge and neurotrophins to cochlear neurons. Biomaterials 2009; 30: 2614-2624.
83. Hahn H, Biegner T, Kammerer B, Delabar U, Salt AN, Plontke SK: Persistence of dexamethasone drug levels and base to apex gradients in the perilymph of the scala tympani after single shot injections through the round window membrane (abstract). J Assoc Res Otolaryngol 2009; 32: 115.
84. Voie AH: Imaging the intact guinea pig tympanic bulla by orthogonal-plane fluorescence optical sectioning microscopy. Hear Res 2002; 171: 119-128.